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Abstract
Background: Group A Streptococcus (Strep A) is an important cause of mortality and morbidity globally. This
bacterium is responsible for a range of different infections and post-infectious sequelae. Summarising the current
knowledge of Strep A transmission to humans will address gaps in the evidence and inform prevention and control
strategies. The objective of this study is to evaluate the modes of transmission and attack rates of group A
streptococcal infection in human populations.
Methods: This systematic review protocol was prepared according to the Preferred Reporting Items for Systematic
reviews and Meta-analysis Protocols (PRISMA-P) 2015 Statement. Using a comprehensive search strategy to identify
any transmission studies that have been published in English since 1980, full-text articles will be identified and
considered for inclusion against predefined criteria. We will include all studies reporting on Strep A transmission,
who have identified a mode of transmission, and who reported attack rates. Risk of bias will be appraised using an
appropriate tool. Our results will be described narratively and where feasible and appropriate, a meta-analysis
utilizing the random-effects model will be used to aggregate the incidence proportions (attack rates) for each
mode of transmission. In addition, we will also evaluate the emm genotype variants of the M protein causing Strep
A infection and the association with transmission routes and attack rates, if any, by setting, socioeconomic
background and geographical regions.
Discussion: We anticipate that this review will contribute to elucidating Strep A modes of transmission which in
turn, will serve to inform evidence-based strategies including environmental health activities to reduce the
transmission of Strep A in populations at risk of severe disease.
Trial registration: Systematic review registration: PROSPERO (CRD42019138472).
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Background
Streptococcus pyogenes, also known as Group A Strepto-
coccus (Strep A), is responsible for a wide range of dis-
eases and is in the top 10 pathogens globally causing
morbidity and mortality, particularly in disadvantaged
settings around the world [1]. Strep A causes superficial
infections (pharyngitis, impetigo, scarlet fever), invasive
infections (cellulitis, skeletal infections, sepsis, necrotis-
ing fasciitis, and toxic shock syndrome), and post-
infectious immune-mediated sequelae (acute rheumatic
fever/rheumatic heart disease, post-streptococcal glom-
erulonephritis). The prevalence of rheumatic heart dis-
ease is estimated to be 33 million (95% confidence
interval (CI), 29.7 million to 43.1 million) cases globally
and the cause of 319,000 (95% CI, 297,000 to 337,300)
deaths each year [2]. Given the unavailability of a vac-
cine, treatment options for Strep A infections rely on an-
tibiotics, predominantly penicillin [3–5]. There are > 220
different Strep A emm types classified according to the
amino acid sequence of M proteins found on the bacter-
ial cell wall [6]. Epidemiological studies have reported an
association of emm type with different disease manifesta-
tions, populations and climate [1, 7–11].
Modes of transmission for pathogens are classified as
contact (both direct and indirect), droplet or airborne.
Vehicle or biological vectors may also play a role in dis-
ease transmission [12]. Traditionally, transmission of
Strep A has been primarily attributed to large respiratory
droplets [13–18] based on studies that used one of two
methods: (a) evaluating the saliva of patients who had
sore throat and scarlet fever, and (b) environmental epi-
demiology which involved measuring the quantity of
Strep A discharged into the air in a controlled room
through coughing, sneezing and talking. More recently,
a combination of methodological approaches including
culture from biological swabs, environmental swabs, and
environmental settle plates have elucidated additional
modes of transmission. These include nasal secretions,
sputum or spit (droplet) [19, 20], small airborne parti-
cles, e.g. dust (airborne) [20–24], skin-to-skin contact
(direct contact) [19, 25–27], surfaces (indirect contact)
[28–30], bedding and fabrics (indirect contact) [31–33],
food (vehicle) [34, 35], and insects (biological vectors)
[36–38]. Both the infectious and carrier state may lead
to transmission, dominated by the infectious state [39,
40]. A few studies have reported Strep A transmission
from carriers to uninfected individuals who have subse-
quently become symptomatic [41–44].
In addition to the pathogen characteristics and mode
of transmission, some settings may influence the risk of
Strep A infection. The household setting, which provides
an extended duration of exposure to individuals with
Strep A, is associated with an increased risk of transmis-
sion and subsequent infection [44–46]. Close household
contacts of patients with invasive Strep A infection have
approximately 2000 times the risk of also developing in-
vasive Strep A infection, most noticeable in mother-
neonate pairs and cohabiting partners > 74 years old
[47]. Infection with Strep A in households is associated
with an increased risk of post-streptococcal sequelae,
e.g. acute rheumatic fever (ARF) and rheumatic heart
disease (RHD) [48]. In a study conducted in Australia,
around 9% of newly diagnosed children with ARF have a
sibling with RHD [49]. Similarly, in New Zealand [50]
and Uganda [51], siblings of children living with RHD
were 2 and 4.5 times more likely to have RHD detected
by echocardiography, respectively. Overcrowded house-
holds and limited household hygiene facilities are likely
to compound these risk factors [52]. Institutional set-
tings, including hospitals and aged care facilities, also
present the risk of nosocomial spread of Strep A infec-
tions. This can be increased by lapses in infection con-
trol measures, posing a significant risk to both
healthcare workers and patients [53–56].
Transmission-based precautions are a crucial compo-
nent of infection control [57]. Understanding the modes
of transmission of Strep A infection will allow strategies
to focus on interrupting these modes of exposure and
reduce the risk of disease. To date, no evidence-based
synthesis has been undertaken to understand the various
modes of transmission of Strep A. The objectives of this
review are to (1) synthesize the evidence of modes of
transmission for Strep A, (2) calculate and compare at-
tack rates against mode of transmission, and (3) correl-
ate emm types of Strep A isolated from clinical swabs
and mode of transmission, where possible.
Methods
This protocol has been written in accordance with the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses Protocol (PRISMA-P) guidelines (Add-
itional file 1) [58]. The protocol is registered with PROS-
PERO (CRD42019138472).
Eligibility criteria
Studies will be selected according to the following cri-
teria: participants, study designs, condition/exposure(s),
and outcome(s) of interest.
Inclusion criteria
1. We will include studies involving children,
adolescents, and adults regardless of age, gender,
health conditions, or other sociodemographic
characteristics.
2. All study designs (including but not limited to case
series, outbreak investigations, cross-sectional, co-
hort and case-control studies) investigating modes
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of transmission of Strep A to humans resulting in
human Strep A infection (both symptomatic disease
with clinical relevance to Strep A infection and
asymptomatic carriage) will be included. Where
available, posters and abstracts will be included sep-
arately under ‘partially published research’ to avoid
publication bias and skewing of cohort results due
to poor ratings in study quality assessment from the
limited availability of full-text publications.
3. Studies that proposed a mode of transmission will
be included, regardless of use of molecular typing to
confirm the mode. Transmission modes that will be
reviewed: include airborne, droplet, contact (direct,
indirect), vehicle, and biological vectors.
4. Household (or familial) and healthcare worker
acquisition will be included even if there is no
designated mode of transmission implicated in the
study.
5. Studies published in English between January 1980
and December 2019.
Exclusion criteria
1. Where duplicate publications are identified, the
most recent version will be included.
2. Narrative reviews, opinion pieces, letters, and
articles lacking primary attack rate data.
3. Laboratory based research, including that which
only analysed emm types associated with outbreaks.
4. Articles addressing symptoms, diagnostic method,
or treatment choice in outbreaks.
5. Outbreak summaries with no mention of
transmission modes.
6. Articles which summarise an infection trend rather
than outbreaks.
Condition being studied
All Strep A infections and sequelae will be assessed, in-
cluding asymptomatic carriage. There will be no restric-
tions on the participants’ age, gender, health conditions,
and demographics for inclusion.
Types of outcome measures
There will be two outcome measures: firstly, docu-
mented evidence of Strep A transmission by different
modes; and secondly, the attack rate of people with
Strep A infection (symptomatic) and detection (asymp-
tomatic carriage). Attack rates will be calculated as the
number of people who had Strep A isolated divided by
the number of people at risk of becoming ill from Strep
A. Attack rates between each of the mode of transmis-
sion will be compared.
Definitions
Modes of transmission can be both direct and indirect
[12], and include:
a) Airborne, e.g. infectious agents carried by fine
expectorate sputum of dust suspended in air,
b) Droplet, e.g. produced by sneezing, coughing, and
talking.
c) Contact, e.g. skin-to-skin or contact with a contam-
inated environment)
d) Vehicles, e.g. inanimate objects that can indirectly
transmit an infectious agent include food, water,
bodily fluids, and fomites and
e) Vectors (e.g. flies, mosquitoes, fleas which can carry
an infectious agent through mechanical or
biological means
Search strategy and information sources
The primary source of literature will be a structured
search strategy for PubMed (Additional file 2) and will
be adapted for use in other databases including Scopus,
EMBASE, Web of Science, and CINAHL. The secondary
source of potentially relevant material will be a search of
grey literature which includes WHO IRIS library data-
base, Trove, Research Data Australia, the Grey Literature
Report, and Australian Infection Prevention and Control.
For clinical trial registries, the Cochrane Central Register
of Clinical Trials, WHO International Clinical Trials
Registry Platform, Australian New Zealand Clinical Trial
Registry, and ClinicalTrial.gov. We will also search refer-
ence lists of included studies for any potentially relevant
articles. The search will be restricted to studies pub-
lished in English between January 1980 and December
2019. The literature searches will be designed and con-
ducted by the review team with experience in developing
search terms for a comprehensive search strategy.
Screening and selection procedure
Titles and abstracts identified by the literature search
will be screened for possible inclusion by two reviewers
(RX/DB/JP) based on the eligibility criteria described
above. Secondly, full-text articles will be evaluated for
inclusion (JD/SE) with independent data extraction com-
pleted by two reviewers (JD/SE/TM) using a standar-
dised data collection form in Microsoft Excel, with
discrepancies adjudicated by a third author (AB).
Thirdly, references of all considered articles will be
hand-searched to identify any relevant reports missed by
the search strategy.
Data extraction
A summary of the data to be collected is shown in Table 1.
We will assess the molecular techniques (e.g. typing and
pulse field gel electrophoresis (PFGE)) used to confirm the
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mode of Strep A transmission. Data collection will be re-
corded in a Microsoft Excel spreadsheet and will be tested
by the team before data collection will commence. Discrep-
ancies will be resolved by discussion and consensus involv-
ing a third author. Partially published studies will have the
data extraction limited to location, setting, attack rate, and
proposed mode of transmission. Where data are missing or
incomplete, primary authors will be contacted to seek add-
itional data.
Assessment of risk of bias
Risk of bias will be assessed independently by two re-
viewers using the Critical Appraisal tool from the Joanna
Briggs Institute [59]. Each domain will be assessed as
‘yes’ or ‘no’ with a tally of the number of ‘yes’ results
reflected in the total score. In addition, for the question
which addresses the appropriateness of statistical ana-
lysis used in each study, we will assess whether the nu-
merator and denominator were reported to calculate the
attack rate.
Data synthesis
Data will be reported according to modes of transmis-
sion. Where household and healthcare worker transmis-
sion studies specify only a designated method of
acquisition rather than a mode of transmission, or where
different strains have been identified between environ-
mental and clinical Strep A isolates, these studies will be
included for qualitative assessment and the synthesis of
data will be reported according to the synthesis without
meta-analysis (SWiM) guidelines [60].
Studies will be included in a meta-analysis if molecular
techniques have been applied to identify common Strep
A strains obtained from clinical and environmental
swabs. Data will be analysed using STATA version 16
(StataCorp, College Station, TX, USA). Our analysis will
calculate attack rates of Strep A infection in the respect-
ive studies, i.e. number of people infected divided by
number of people exposed, which will thereafter, be sub-
jected to meta-analysis (random-effects model, due to
the expected variability across the studies) to derive
summary attack rate estimates (overall pooled estimate
with the pooled 95% CI). In addition, we will derive
standard errors (SE) where studies have provided the nu-
merator and denominators to calculate the attack rates
for Strep A. Attack rates of the different studies will be
analysed, and the pooled estimates will be conducted
using the Metaprop package. The pooled rates will be
estimated using the Freeman-Tukey double arcsine
transformation method to stabilise the variance of attack
rates within each study [61].
Heterogeneity between included studies will be
assessed using the I2 heterogeneity statistic, reported as
a percentage to determine the extent of variation be-
tween the studies [62]. Deeks [62] defines categories of
heterogeneity with a value ≤ 25% as low, 26–50% moder-
ate, 51–75% substantial, and 76–100% as considerable
heterogeneity. Where heterogeneity is statistically signifi-
cant, a sensitivity analysis will be conducted to explore
potential sources of heterogeneity and to establish if the
meta-analysis results are influenced by the effect of the
quality of the studies (risk of bias) or sample size. Where
available, a subgroup analysis will be conducted for the
attack rates of Strep A in patients from different settings
(nosocomial, domestic and public settings) and for dif-
ferent geographical regions (Northern or Southern hemi-
sphere). There is, however, the potential that there may
be significant diversity in the included studies in terms
of setting, population, disease, and attack rates, so as to
not render the data amenable to pooling. Should hetero-
geneity exist, or if attack rates are not reported or can-
not be calculated, results will be discussed in a narrative
review.
By using appropriate strategies, we will minimize the
potential biases in the review process. Unpublished pa-
pers, grey literature, and preprints will be included in
the review. Potential publication biases will be explored
with graphic assessment using Funnel plots. Funnel plots
are recommended when there are at least 10 studies in-
cluded for meta-analysis.
Table 1 Data to be collected in the data extraction of included studies












• Health conditions which might increase the risk of Strep A infection
or carriage, e.g. immunodeficiency states (immunocompetent or
immunocompromised) or underlying diseases
• Modes of Strep A transmission
• Types of Strep A infections
• Symptoms
• Strep A emm strains
• Time period in which transmission occurred
• Season of participation
• Number of people exposed (denominator)
• Numbers of people with Strep A infected/
detected (only primary transmission)
(numerator)
• Number of deaths
• Asymptomatic carriage rates
• Sampling method used to collect samples
• Laboratory methods used to analyse samples
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Discussion
This systematic review seeks to provide robust contem-
porary evidence for the modes involved in Strep A trans-
mission. The rigorous methods to be used in this
systematic review will ensure robust synthesis of avail-
able data to provide empirical evidence necessary for re-
searchers, policy-makers, public health, and
environmental health stakeholders, thus reducing the
burden of all Strep A causing invasive, non-invasive, and
immune-mediated diseases. Given that the burden of se-
vere Strep A disease is concentrated in developing coun-
tries and among Indigenous populations living in
developed countries, this review can help establish rec-
ommendations to reduce the disproportionate impact on
marginalised populations globally. A limitation of the re-
view is the inclusion of non-randomised and observa-
tional studies that consequently will result in a high
variability across included studies.
We do not expect any protocol amendments arising.
However, should any amendments be deemed necessary,
it will be reported in the published review.
The results of this review will be disseminated in the
form of a peer-reviewed journal article and findings will
also be presented to relevant health authorities and med-
ical services working in remote regions.
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